Kliniske studier af åbne, sekundært inficerede sår viste utilstrækkelig virkning af retapamulin hos patienter, der var inficerede med methicillin- resistente Staphylococcus aureus (MRSA).
In clinical studies of secondarily infected open wounds, the efficacy of retapamulin was inadequate in patients with infections caused by methicillin-resistant Staphylococcus aureus (MRSA).